4//SEC Filing
ACCENTIA BIOPHARMACEUTICALS INC 4
Accession 0001181431-10-063091
CIK 0001310094operating
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 4:40 PM ET
Size
5.0 KB
Accession
0001181431-10-063091
Insider Transaction Report
Form 4
Pearce Alan M
DirectorChief Financial Officer
Transactions
- Other
Common Stock
2010-12-17+206,896→ 1,194,403 total
Footnotes (1)
- [F1]Represents acquisition of common stock of Accentia Biopharmaceuticals, Inc. by reporting person from a third-party in a private transaction.
Documents
Issuer
ACCENTIA BIOPHARMACEUTICALS INC
CIK 0001310094
Entity typeoperating
IncorporatedFL
Related Parties
1- filerCIK 0001310094
Filing Metadata
- Form type
- 4
- Filed
- Dec 20, 7:00 PM ET
- Accepted
- Dec 21, 4:40 PM ET
- Size
- 5.0 KB